That's what Seeking Alpha is stating. I don't see
Post# of 36537
"It is also mulling a spinout of NuGenerex Immuno-Oncology after which it will operate independently with its own stock listing. Specifically, the spinout will be executed by issuing one or more dividends of NuGenerex stock to GNBT shareholders. GNBT expects to retain a controlling interest."